Welcome to the Xendo website
Xendo is a leading, independent consultancy and project management organization in the life sciences, pharmaceutical and healthcare fields. Our ambition is to enhance the quality and safety of medicine and help shorten the time to market for drugs and medical devices that improve the quality of life.
For over 20 years we have supported hundreds of clients in more than 25 countries worldwide. For further information please contact us at firstname.lastname@example.org. Or just click one of the buttons to find out what Xendo can do in your area of expertise.
Press release: Xendo announces management buy-out supported by Sovereign Capital
The investment will strengthen the company’s position as a leading consultant and it will have a positive effect on the continuity of business. Current customers will continue to seamlessly enjoy existing services, and Xendo will be able to seek to expand its services and geographical reach, both through organic growth and complementary acquisitions. With a strong track-record as a ‘Buy & Build’ specialist, Sovereign Capital will provide the financial support to grow, develop and expand Xendo.
Under the new ownership the business will continue to operate under its own name. We are also delightedto welcome CFO, Arjen Huijs (previously Jacobs Douwe Egberts) to the current management team.
Xendo makes the Dutch Financial Times (Financieel Dagblad) again!
Xendo´s recent management buy-out by Sovereign Capital has grabbed the attention of the Dutch Financial Times, which placed an article about it today.
In response to questions by FD-journalist Thieu Vaassen, André van de Sande (CEO) gives insight in Xendo´s successful turnaround over the past 5 years.